Mastoid Obliteration Decreases the Recurrent and Residual Disease: Systematic Review and Meta-analysis.
Illés K, Meznerics FA, Dembrovszky F, Fehérvári P, Bánvölgyi A, Csupor D, Hegyi P, Horváth T.
Illés K, et al.
Laryngoscope. 2023 Jun;133(6):1297-1305. doi: 10.1002/lary.30413. Epub 2022 Sep 28.
Laryngoscope. 2023.
PMID: 36169349
Review.
The exclusion criteria were less than 12 months follow-up, congenital cholesteatoma, indefinite description of the surgical method, and animal studies. ...CONCLUSION: Mastoid obliteration significantly decreased the proportion of residual and recurrent cholesteatoma …
The exclusion criteria were less than 12 months follow-up, congenital cholesteatoma, indefinite description of the surgical method, a …